Implementation of PROs in daily oncology care before and during the SARS-CoV-2 pandemic : real world experience
Source
Antwerpen, Universiteit Antwerpen, Faculteit Geneeskunde en Gezondheidswetenschappen, 2023,120 p.
Boosting capacity of a fourth dose BNT162b2 in cancer patients
Source
European journal of cancer - ISSN 0959-8049-179 (2023) p. 121-123
Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in patients with cancer
Source
Clinical cancer research - ISSN 1078-0432-29:3 (2023) p. 635-646
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study
Source
Cancer immunology and immunotherapy - ISSN 0340-7004-72:2 (2023) p. 475-491
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors
Source
Frontiers in immunology - ISSN 1664-3224-13 (2022) p. 1-10